Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Director | May 18, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date May 18, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 128,318 |
Reported balance
After 2026-05-18 transaction · row 1
1 source rowRow 1 · 2026-05-18 · Grant · Acquired 6,144 · Balance 128,318 F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ENTELLUS MEDICAL INC
Report date February 28, 2018 · Filed March 01, 2018
Section 16 reporting ended · disclosed 2018-03-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 1
1 source rowRow 1 · 2018-02-28 · Disposition to issuer · Disposed 53,199 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.36 · Expires 2024-12-16 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-02-28 · Disposition to issuer · Disposed 463,325 · Balance 0 F2: This option, which provided for vesting of 25% of the shares on November 24, 2015 and 36 equal monthly installments thereafter, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.36 · Expires 2024-12-16 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-02-28 · Disposition to issuer · Disposed 270,275 · Balance 0 F3: This option, which provided for vesting in 48 equal monthly installments commencing on May 2, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.99 · Expires 2026-01-04 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-02-28 · Disposition to issuer · Disposed 135,000 · Balance 0 F4: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.01 · Expires 2027-01-04 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-02-28 · Disposition to issuer · Disposed 76,000 · Balance 0 F5: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
F2: This option, which provided for vesting of 25% of the shares on November 24, 2015 and 36 equal monthly installments thereafter, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
F3: This option, which provided for vesting in 48 equal monthly installments commencing on May 2, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
F4: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
F5: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 20, 2026 13:25 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 6,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001571208-26-000005 · wk-form4_1779283512.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,318 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 12:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 10,000 | $14.99 Strike: $14.99 | $149,900.00 |
DisclosureSEC source: 0001571208-26-000002 · wk-form4_1773319961.xml · derivative · entry 2 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Non-qualified Stock Option (right to buy) · 10,000 shares Expires 2026-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on May 25, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 12:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $14.99 | $149,900.00 |
DisclosureSEC source: 0001571208-26-000002 · wk-form4_1773319961.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:42 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-25-000064 · wk-form4_1747860166.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,174 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 05, 2025 Filed May 7, 2025 12:25 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 10,000 | $22.62 Strike: $22.62 | $226,200.00 |
DisclosureSEC source: 0001323885-25-000048 · wk-form4_1746620705.xml · derivative · entry 2 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on May 20, 2015. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| May 05, 2025 Filed May 7, 2025 12:25 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $22.62 | $226,200.00 |
DisclosureSEC source: 0001323885-25-000048 · wk-form4_1746620705.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2024 Filed May 14, 2024 21:06 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 7,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-24-000084 · wk-form4_1715720766.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,773 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 14:00 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 10,000 | $15.96 Strike: $15.96 | $159,600.00 |
DisclosureSEC source: 0001323885-24-000022 · wk-form4_1709042411.xml · derivative · entry 2 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Non-qualified Stock Option (right to buy) · 10,000 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on May 14, 2014. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 14:00 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 10,000 | $15.96 | $159,600.00 |
DisclosureSEC source: 0001323885-24-000022 · wk-form4_1709042411.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:29 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 3,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-23-000067 · wk-form4_1685132919.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,985 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 20,000 | $8.48 Strike: $8.48 | $169,600.00 |
DisclosureSEC source: 0001323885-23-000017 · wf-form4_167770754682631.xml · derivative · entry 2 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Non-qualified Stock Option (right to buy) · 20,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on March 11, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 20,000 | $8.48 | $169,600.00 |
DisclosureSEC source: 0001323885-23-000017 · wf-form4_167770754682631.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:03 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 15,000 | $8.48 Strike: $8.48 | $127,200.00 |
DisclosureSEC source: 0001323885-22-000106 · wf-form4_166214901703770.xml · derivative · entry 2 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Non-qualified Stock Option (right to buy) · 15,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on March 11, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:03 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 15,000 | $8.48 | $127,200.00 |
DisclosureSEC source: 0001323885-22-000106 · wf-form4_166214901703770.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 27, 2022 13:04 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 3,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-22-000078 · wf-form4_165365667224439.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,799 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 12:55 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionNon-qualified Stock Option (right to buy) · Derivative | 15,000 | $8.48 Strike: $8.48 | $127,200.00 |
DisclosureSEC source: 0001323885-22-000035 · wf-form4_164665771106015.xml · derivative · entry 2 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Non-qualified Stock Option (right to buy) · 15,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on March 11, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 12:55 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 15,000 | $8.48 | $127,200.00 |
DisclosureSEC source: 0001323885-22-000035 · wf-form4_164665771106015.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 25, 2021 00:08 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035552 · doc4.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,235 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 12:35 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031566 · doc4.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,486 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 12:36 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032552 · doc4.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,034 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 20:46 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033007 · doc4.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,826 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 14:02 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | Disposition to issuerStock Option (right to buy) · Derivative | 76,000 | $4.99 Strike: $19.01 | $379,240.00 |
DisclosureSEC source: 0001235802-18-000021 · primary_doc.xml · derivative · entry 5 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,000 shares Expires 2027-01-04 F5 · derivative.exercise_date: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 14:02 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | Disposition to issuerStock Option (right to buy) · Derivative | 135,000 | $7.01 Strike: $16.99 | $946,350.00 |
DisclosureSEC source: 0001235802-18-000021 · primary_doc.xml · derivative · entry 4 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 135,000 shares Expires 2026-01-04 F4 · derivative.exercise_date: This option, which provided for vesting in 48 equal monthly installments commencing on February 4, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 14:02 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | Disposition to issuerStock Option (right to buy) · Derivative | 270,275 | $12.64 Strike: $11.36 | $3,416,276.00 |
DisclosureSEC source: 0001235802-18-000021 · primary_doc.xml · derivative · entry 3 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 270,275 shares Expires 2024-12-16 F3 · derivative.exercise_date: This option, which provided for vesting in 48 equal monthly installments commencing on May 2, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 14:02 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | Disposition to issuerStock Option (right to buy) · Derivative | 463,325 | $12.64 Strike: $11.36 | $5,856,428.00 |
DisclosureSEC source: 0001235802-18-000021 · primary_doc.xml · derivative · entry 2 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 463,325 shares Expires 2024-12-16 F2 · derivative.exercise_date: This option, which provided for vesting of 25% of the shares on November 24, 2015 and 36 equal monthly installments thereafter, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 14:02 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | Disposition to issuerCommon Stock, $0.001 par value | 53,199 | $24.00 | $1,276,776.00 |
DisclosureSEC source: 0001235802-18-000021 · primary_doc.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 16:32 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | SaleCommon Stock, $0.001 par value | 3,471 | $24.01 | $83,338.71 |
DisclosureSEC source: 0001235802-18-000009 · primary_doc.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,199 F1 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F2 · balance_after: Includes 28,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan and an aggregate of 2,788 shares acquired under the Entellus Medical, Inc. 2015 Employee Stock Purchase Plan on June 30, 2016 and June 30, 2017. Read SEC document |
| May 24, 2017 Filed May 25, 2017 21:01 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035471 · doc4.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,605 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 08, 2017 Filed May 8, 2017 17:49 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | PurchaseCommon Stock, $0.001 par value | 10,000 | $12.24 | $122,400.00 |
DisclosureSEC source: 0001235802-17-000049 · primary_doc.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,353 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.70 to $12.25, inclusive. The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Includes 38,000 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan. F3 · balance_after: Includes 1,471 shares acquired under the Entellus Medical, Inc. 2015 Employee Stock Purchase Plan on June 30, 2016. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:20 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | GrantNon-Statutory Stock Option (right to buy) · Derivative | 76,000 | $0.00 Strike: $19.01 | $0.00 |
DisclosureSEC source: 0001235802-17-000011 · primary_doc.xml · derivative · entry 2 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,000 Underlying: Common Stock · 76,000 shares Expires 2027-01-04 F3 · derivative.exercise_date: This option vests with respect to 1/48th of the shares on February 4, 2017 and on each monthly anniversary of January 4, 2017 thereafter, subject to such Reporting Person's continued employment with Entellus Medical, Inc. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:20 UTC | ENTELLUS MEDICAL INC ENTL · Entity 16119 | GrantCommon Stock, $0.001 par value | 38,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-17-000011 · primary_doc.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,353 F1 · shares: These shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan. F1 · balance_after: These shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan. F2 · balance_after: Includes 1,471 shares acquired under the Entellus Medical, Inc. 2015 Employee Stock Purchase Plan on June 30, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.